Werner Scheuer

Strongly Enhanced Antitumor Activity of Trastuzumab and Pertuzumab Combination Treatment on HER2-Positive Human Xenograft Tumor Models

Werner Scheuer, Thomas Friess, Helmut Burtscher et al. · Cancer Research · 2009 · 617 citations · Full text

Breast Oncology, Immunology, Tumor Biology +17

Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies

Wolfgang Schaefer, Jörg T. Regula, Monika Bähner et al. · Proceedings of the National Academy of Sciences · 2011 · 457 citations · Full text

Immunocytochemical Technique, Immunology, Immunodominance +26

Interleukin‐16 stimulates the expression and production of pro‐inflammatory cytokines by human monocytes

Nathalie Mathy, Werner Scheuer, Martin Lanzendörfer et al. · Immunology · 2000 · 255 citations · Full text

Ang-2-VEGF-A CrossMab, a Novel Bispecific Human IgG1 Antibody Blocking VEGF-A and Ang-2 Functions Simultaneously, Mediates Potent Antitumor, Antiangiogenic, and Antimetastatic Efficacy

Yvonne Kienast, Christian Klein, Werner Scheuer et al. · Clinical Cancer Research · 2013 · 197 citations

Cancer-related issues of CD147.

Ulrich H. Weidle, Werner Scheuer, Daniela Eggle et al. · PubMed · 2010 · 170 citations

Tumor Biology, Amino Acid Transporters, Malignant Disease +15